pembrolizumab
merck
['pembro']
#esmo22 no significant benefit under pembro + crt vs placebo + crt in locally advanced untreated hnscc. potential role of pd-l1 as a predictive marker. 
Cancer researcher; Director of GU Cancers @DanaFarber; Prof of Medicine @HarvardMed; ? lover; ??@PanMass
Views are mine.